How Staphylococcus aureus and Pseudomonas aeruginosa Hijack the Host Immune Response in the Context of Cystic Fibrosis

Int J Mol Sci. 2023 Apr 1;24(7):6609. doi: 10.3390/ijms24076609.

Abstract

Cystic fibrosis (CF) is a serious genetic disease that leads to premature death, mainly due to impaired lung function. CF lungs are characterized by ongoing inflammation, impaired immune response, and chronic bacterial colonization. Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) are the two most predominant bacterial agents of these chronic infections. Both can colonize the lungs for years by developing host adaptation strategies. In this review, we examined the mechanisms by which SA and PA adapt to the host immune response. They are able to bypass the physical integrity of airway epithelia, evade recognition, and then modulate host immune cell proliferation. They also modulate the immune response by regulating cytokine production and by counteracting the activity of neutrophils and other immune cells. Inhibition of the immune response benefits not only the species that implements them but also other species present, and we therefore discuss how these mechanisms can promote the establishment of coinfections in CF lungs.

Keywords: P. aeruginosa; S. aureus; cystic fibrosis; immune response.

Publication types

  • Review

MeSH terms

  • Cystic Fibrosis* / microbiology
  • Humans
  • Immunity
  • Lung / microbiology
  • Pseudomonas Infections* / microbiology
  • Pseudomonas aeruginosa / physiology
  • Staphylococcal Infections* / microbiology
  • Staphylococcus aureus / physiology